dextroamphetamine has been researched along with Cataleptic Attacks in 11 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Five patients with narcolepsy (four with the allied symptom of cataplexy) were treated with the serotonin antagonist methysergide." | 7.65 | Methysergide in the treatment of narcolepsy. ( Troupin, AS; Wilkus, RJ; Wyler, AR, 1975) |
| "Cataplexy was not affected by amphetamine treatment, but was abolished in two patients when clomipramine was given together with either amphetamine." | 6.64 | Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy. ( Fenton, GW; Parkes, JD, 1973) |
| "Selegiline was compared to no treatment (7 subjects) or conventional central stimulant drugs, including dexamphetamine or mazindol (14 subjects)." | 5.27 | Selegiline in narcolepsy. ( Jenner, P; Langdon, N; Lock, CB; Parkes, JD; Roselaar, SE, 1987) |
| "Five patients with narcolepsy (four with the allied symptom of cataplexy) were treated with the serotonin antagonist methysergide." | 3.65 | Methysergide in the treatment of narcolepsy. ( Troupin, AS; Wilkus, RJ; Wyler, AR, 1975) |
| "The clinical symptoms of cataplexy, sleep paralysis, hypnogogic hallucinations, daily naps, and sleep attacks all showed significant improvements." | 2.66 | The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy. ( Brown, D; Brown, L; Hirschowitz, J; Scharf, MB; Woods, M, 1985) |
| "Cataplexy was not affected by amphetamine treatment, but was abolished in two patients when clomipramine was given together with either amphetamine." | 2.64 | Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy. ( Fenton, GW; Parkes, JD, 1973) |
| "Narcolepsy is a disabling disease with a prevalence of 0." | 2.44 | Pediatric narcolepsy. ( Husain, AM; Peterson, PC, 2008) |
| "D-Amphetamine was found to be more potent in increasing DA efflux than L-amphetamine, and L-methamphetamine was found to have little effect on DA efflux; there was no significant difference in the potencies of the three derivatives on NE efflux." | 1.31 | Implication of dopaminergic mechanisms in the wake-promoting effects of amphetamine: a study of D- and L-derivatives in canine narcolepsy. ( Honda, K; Kanbayashi, T; Kodama, T; Mignot, E; Nishino, S, 2000) |
| "Selegiline was compared to no treatment (7 subjects) or conventional central stimulant drugs, including dexamphetamine or mazindol (14 subjects)." | 1.27 | Selegiline in narcolepsy. ( Jenner, P; Langdon, N; Lock, CB; Parkes, JD; Roselaar, SE, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (63.64) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krishnamurthy, VB | 1 |
| Nallamothu, V | 1 |
| Singareddy, R | 1 |
| Christine, CW | 1 |
| Marks, WJ | 1 |
| Ostrem, JL | 1 |
| SOURS, JA | 1 |
| WILLIAMSON, DM | 1 |
| Peterson, PC | 1 |
| Husain, AM | 1 |
| Kanbayashi, T | 1 |
| Honda, K | 1 |
| Kodama, T | 1 |
| Mignot, E | 1 |
| Nishino, S | 1 |
| Wyler, AR | 1 |
| Wilkus, RJ | 1 |
| Troupin, AS | 1 |
| Roselaar, SE | 1 |
| Langdon, N | 1 |
| Lock, CB | 1 |
| Jenner, P | 1 |
| Parkes, JD | 3 |
| Scharf, MB | 1 |
| Brown, D | 1 |
| Woods, M | 1 |
| Brown, L | 1 |
| Hirschowitz, J | 1 |
| Fenton, GW | 1 |
| Fenton, G | 1 |
| Struthers, G | 1 |
| Curzon, G | 1 |
| Kantamaneni, BD | 1 |
| Buxton, BH | 1 |
| Record, C | 1 |
2 reviews available for dextroamphetamine and Cataleptic Attacks
| Article | Year |
|---|---|
NARCOLEPSY AND OTHER DISTURBANCES IN THE SLEEP-WAKING RHYTHM: A STUDY OF 115 CASES WITH REVIEW OF THE LITERATURE.
Topics: Black People; Cataplexy; Craniocerebral Trauma; Depression; Dextroamphetamine; Encephalitis; Halluci | 1963 |
Pediatric narcolepsy.
Topics: Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Child; Dextroamphetamine; Ghreli | 2008 |
2 trials available for dextroamphetamine and Cataleptic Attacks
| Article | Year |
|---|---|
The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Cataplexy; Clinical Trials as Topic; Dextroamphetamin | 1985 |
Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy.
Topics: Adult; Amphetamine; Antidepressive Agents; Cataplexy; Dextroamphetamine; Electroencephalography; Eva | 1973 |
7 other studies available for dextroamphetamine and Cataleptic Attacks
| Article | Year |
|---|---|
An interesting case of late age at onset of narcolepsy with cataplexy.
Topics: Amphetamine; Cataplexy; Central Nervous System Stimulants; Dextroamphetamine; Diagnosis, Differentia | 2014 |
Development of Parkinson's disease in patients with Narcolepsy.
Topics: Adult; Age of Onset; Antiparkinson Agents; Cataplexy; Central Nervous System Stimulants; Deep Brain | 2012 |
A CASE OF LONG-STANDING NARCOLEPSY IN A COALMINER.
Topics: Cataplexy; Coal Mining; Dextroamphetamine; Drug Therapy; Humans; Narcolepsy; Sleep Wake Disorders | 1964 |
Implication of dopaminergic mechanisms in the wake-promoting effects of amphetamine: a study of D- and L-derivatives in canine narcolepsy.
Topics: Amphetamine; Animals; Cataplexy; Caudate Nucleus; Central Nervous System Stimulants; Cerebral Cortex | 2000 |
Methysergide in the treatment of narcolepsy.
Topics: Adult; Cataplexy; Dextroamphetamine; Electroencephalography; Electromyography; Electrooculography; F | 1975 |
Selegiline in narcolepsy.
Topics: Adult; Affect; Aged; Cataplexy; Dextroamphetamine; Humans; Male; Mazindol; Middle Aged; Narcolepsy; | 1987 |
Narcolepsy and cataplexy. Clinical features, treatment and cerebrospinal fluid findings.
Topics: Adult; Amphetamine; Aspartic Acid; Body Weight; Cataplexy; Cerebrospinal Fluid Proteins; Dextroamphe | 1974 |